Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Creative Medical Technology Holdings (CELZ) Return on Equity (2016 - 2025)

Creative Medical Technology Holdings (CELZ) has disclosed Return on Equity for 15 consecutive years, with 1.1% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 8.0% to 1.1% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.1% through Dec 2025, down 8.0% year-over-year, with the annual reading at 1.04% for FY2025, 25.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.1% at Creative Medical Technology Holdings, up from 1.14% in the prior quarter.
  • The five-year high for Return on Equity was 28.95% in Q3 2021, with the low at 1.14% in Q3 2025.
  • Average Return on Equity over 5 years is 1.49%, with a median of 0.65% recorded in 2023.
  • The sharpest move saw Return on Equity skyrocketed 2812bps in 2021, then crashed -2930bps in 2022.
  • Over 5 years, Return on Equity stood at 3.9% in 2021, then tumbled by -114bps to 0.53% in 2022, then grew by 12bps to 0.47% in 2023, then tumbled by -118bps to 1.03% in 2024, then fell by -8bps to 1.1% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.1%, 1.14%, and 0.93% for Q4 2025, Q3 2025, and Q2 2025 respectively.